Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function

Chest

Volumn 147, Issue 1, 2015, Pages 56-67

  Ford, Earl S ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY INJURY; LUNG FUNCTION; MALE; MORTALITY; OBSTRUCTIVE LUNG FUNCTION; UNITED STATES; URINARY ALBUMIN CREATININE RATIO; UROGENITAL SYSTEM PARAMETERS; CAUSE OF DEATH; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS; URINE;

ADULT; AGED; ALBUMINURIA; CAUSE OF DEATH; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84920711968     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2482     Document Type: Article

References (33)

1. Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011; 59 (10): 1-126.
2. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003; 58 (5): 388-393.
3. Ford ES, Mannino DM, Zhao G, Li C, Croft JB. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest. 2012; 141 (1): 101-110.
4. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPDrelated hospitalizations in the United States, 1979 to 2001. Chest. 2005; 128 (4): 2005-2011.
5. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013; 143 (5): 1395-1406.
6. Matsushita K, van der Velde M, Astor BC, et al; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375 (9731): 2073-2081.
7. van der Velde M, Matsushita K, Coresh J, et al; Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative metaanalysis of high-risk population cohorts. Kidney Int. 2011; 79 (12): 1341-1352.
8. Astor BC, Matsushita K, Gansevoort RT, et al; Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011; 79 (12): 1331-1340.
9. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150 (9): 604-612.
10. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006; 17 (8): 2100-2105.
11. Asselbergs FW, Diercks GF, Hillege HL, et al; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004; 110 (18): 2809-2816.
12. Kömürcüoʇlu A, Kalenci S, Kalenci D, Kömürcüoʇlu B, Tibet G. Microalbuminuria in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 2003; 59 (4): 269-272.
13. Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombolysis. 2008; 26 (2): 97-102.
14. Casanova C, de Torres JP, Navarro J, et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182 (8): 1004-1010.
15. Bulcun E, Ekici M, Ekici A, Kisa U. Microalbuminuria in chronic obstructive pulmonary disease. COPD. 2013; 10 (2): 186-192.
16. Centers for Disease Control and Prevention. NHANES III linked mortality file. CDC website. http://www.cdc.gov/nchs/data-access/data-linkage/mortality/nhanes3-linkage.htm. Accessed January 7, 2011.
17. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1. 1994 ;(32): 1-407.
18. Westat, Inc. Third National Health and Nutrition Examination Survey. Spirometry Procedure Manual. CDC website. http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/spiro.pdf. Accessed July 24, 2013.
19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999; 159 (1): 179-187.
20. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002; 39 (5): 920-929.
21. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012; 379 (9811): 165-180.
22. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17 (7): 2034-2047.
23. Fox CS, Matsushita K, Woodward M, et al; Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and endstage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012; 380 (9854): 1662-1673.
24. Mahmoodi BK, Matsushita K, Woodward M, et al; Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a metaanalysis ysis. L ancet. 2012; 380 (9854): 1649-1661.
25. Holtkamp FA, de Zeeuw D, de Graeff PA, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J. 2011; 32 (12): 1493-1499.
26. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of communitybased studies. J Am Soc Nephrol. 2004; 15 (5): 1307-1315.
27. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989; 32 (4): 219-226.
28. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002; 7 (1): 35-43.
29. Atthobari J, Asselbergs FW, Boersma C, et al; PREVEND IT Study Group. Costeffectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther. 2006; 28 (3): 432-444.
30. Boersma C, Gansevoort RT, Pechlivanoglou P, et al; Prevention of Renal and Vascular End Stage Disease Study Group. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. C lin Ther. 2010; 32 (6): 1103-1121.
31. Özyilmaz A, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group. Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors. Nephrol Dial Transplant. 2010; 25 (11): 3560-3568.
32. Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010; 14 (21): 1-184.
33. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013; 3 (1): 1-150.